Management tracks: Trio of female exec appointments; plus FDA, Cell and Gene Therapy Catapult, SutroVax, Lundquist Institute, RedShift, NeoImmuneTech and more

Three women were appointed this week to C-suite positions at biotechs with valuations over $1 billion. The hires come the same week as a report from BIO that found that about 30% of biotech executives are female (see “Biotech Diversity is Still Lacking”).

In addition to Laurence De Moerlooze, who will become CMO of Bavarian Nordic A/S (CSE:BAVA; Pink:BVNRY) in April, rare disease company Insmed Inc. (NASDAQ:INSM) hired Sara Bonstein as CFO and mRNA therapeutics play Moderna Inc. (NASDAQ:MRNA) hired Melanie Ivarsson as chief development officer. Bonstein was CFO and COO of OncoSec Medical Inc. (NASDAQ:ONCS) and Ivarsson was VP, head of global clinical operations at Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK)...